OSMT - Osmotica Pharmaceuticals EPS beats by $0.04 misses on revenue November, 15 2021 04:24 PM Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals (NASDAQ:OSMT): Q3 GAAP EPS of -$0.28 beats by $0.04. Revenue of $2.19M (-96.2% Y/Y) misses by $0.17M. Press Release For further details see: Osmotica Pharmaceuticals EPS beats by $0.04, misses on revenue